Chanel
This article was originally published in The Rose Sheet
Executive Summary
Michael Steiger, PhD, appointed senior VP-R&D, reporting to President and Chief Operating Officer Arie Kopelman. Previously Juvena/La Prairie VP-R&D, Steiger will work with Chanel American, European and Asian teams "to leverage and translate international scientific findings into innovative products," firm says. He also will serve as key spokesman on technical issues, new product introductions and trends for Chanel beauty and fragrance brands
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.